Merz, M., Salwender, H., Haenel, M., Mai, E. K., Bertsch, U., Kunz, C., . . . Goldschmidt, H. (2016). Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial. Haematologica.
Citação norma ChicagoMerz, Maximilian, et al. "Peripheral Neuropathy Associated With Subcutaneous or Intravenous Bortezomib in Patients With Newly Diagnosed Myeloma Treated Within the GMMG MM5 Phase III Trial." Haematologica 2016.
Citação norma MLAMerz, Maximilian, et al. "Peripheral Neuropathy Associated With Subcutaneous or Intravenous Bortezomib in Patients With Newly Diagnosed Myeloma Treated Within the GMMG MM5 Phase III Trial." Haematologica 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.